Education
About Us
Working with TipRanks
Follow Us
Muna Bhanji Insider Profile
4 Followers
Muna Bhanji, Director at Cytokinetics, holds 19.47K shares in Intellia Therapeutics (Ticker: NTLA), holds 34.58K shares in Veracyte (Ticker: VCYT), holds 17.63K shares in Cytokinetics (Ticker: CYTK).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-20.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Muna Bhanji holds in companies
Most Profitable Insider Trade
The most profitable trade made by Muna Bhanji
Muna Bhanji's Trading History
Cytokinetics
Jun 10, 2024
Director
Informative Sell
104.14K
$765.71K
Ardelyx
Jun 17, 2022
Director
Uninformative Buy
―
$507.75K
Veracyte
Jun 17, 2024
Director
Uninformative Buy
―
$1.11M
Intellia Therapeutics
Jan 31, 2025
Director
Uninformative Sell
2.64K
$201.49K
List of latest transactions for each holding click on a transaction to see Muna Bhanji's performance on stock
You May Also Like
Muna Bhanji insider profile FAQ
What is the percentage of profitable transactions made by Muna Bhanji?
The percentage of profitable transactions made by Muna Bhanji is 50%.
What is the average return per transaction made by Muna Bhanji?
The average return per transaction made by Muna Bhanji is -20.00%.
What stocks does Muna Bhanji hold?
Muna Bhanji holds: CYTK, ARDX, VCYT, NTLA stocks.
What was Muna Bhanji’s latest transaction?
Muna Bhanji latest transaction was an Uninformative Sell of $2.64K.
What was Muna Bhanji's most profitable transaction?
Muna Bhanji’s most profitable transaction was an Informative Sell of CYTK stock on June 10, 2024. The return on the trade was 19.80%.
What is Muna Bhanji's role in Cytokinetics?
Muna Bhanji's role in Cytokinetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.